Interaction of bioactive components caffeoylquinic Acid derivatives in Chinese medicines with bovine serum albumin.
(9/38)
Five caffeoylquinic acid derivatives (CQAs), including methyl 3,4-di-O-caffeoylquinate (3,4-diCQM), methyl 3,5-di-O-caffeoylquinate (3,5-diCQM), 3,4-di-O-caffeoylquinic acid (3,4-diCQA), 3,5-di-O-caffeoylquinic acid (3,5-diCQA) and chlorogenic acid (CA), were isolated from Lonicera fulvotomentosa HSU et S. C. CHENG to be used as model compounds. The binding of these bioactive components to bovine serum albumin (BSA) was investigated by fluorescence quenching method. The results showed that there were binding affinities for CQAs with BSA, and the binding constants ranked in the following order: 3,4-diCQM>3,5-diCQM<3,4-diCQA>3,5-diCQA>CA, under the physiological conditions, which suggested that the numbers and the substituted positions of caffeoyl group as well as the esterification of carboxyl group in the molecular structures appeared to contribute moderate effects to the interaction processes. Furthermore, the Stern-Volmer curves demonstrated that CQAs caused the fluorescence quenching through a static quenching procedure. Thermodynamic analysis indicated that both hydrophobic and electrostatic interactions played major roles in stabilizing the complex. The binding distance for each binding reaction was also calculated by the Foster theory. (+info)
Berry fruits as a source of biologically active compounds: the case of Lonicera caerulea.
(10/38)
BACKGROUND: Lonicera caerulea L. (blueberry honeysuckle, Caprifoliaceae) is a traditional crop in northern Russia, China, and Japan. Its fruits are little known as edible berries in North America and Europe. This review deals with the botany and chemical composition of L. caerulea and the biological activity of its main constituents, focusing on the potential health benefits of the berries. METHODS AND RESULTS: PubMed, Science Direct and ISI Web of Knowledge databases were used for this paper. Literature sources include the period 1935-2007. L. caerulea berries a are rich source of phenolic compounds such as phenolic acids as well as anthocyanins, proanthocyanidins and other flavonoids, which display potential health promoting effects. Chemopreventive, antimicrobial, anti-adherence and antioxidant benefits, among others are described for these compounds. CONCLUSIONS: The potential of L. caerulea berries to prevent chronic diseases such as diabetes mellitus, cardiovascular diseases and cancer seems to be related above all to their phenolic content. (+info)
The antioxidant response induced by Lonicera caerulaea berry extracts in animals bearing experimental solid tumors.
(11/38)
Lonicera caerulea is a species of bush native to the Kamchatka Peninsula (Russian Far East) whose berries have been extensively studied due to their potential high antioxidant activity. The aim of our work was to investigate the in vivo effects of the antioxidant action of Lonicera caerulea berry extracts on the dynamics of experimentally-induced tumors. Our data showed that aqueous Lonicera caerulaea extracts reduced the tumor volume when administered continuously during the tumor growth and development stages, but augmented the tumor growth when the administration of extracts started three weeks before tumor grafting. Prolonged administration of Lonicera caerulaea berry extracts induced the antioxidant defense mechanism in the tumor tissues, while surprisingly amplifying the peripheral oxidative stress. (+info)
Replication promiscuity of DNA-beta satellites associated with monopartite begomoviruses; deletion mutagenesis of the Ageratum yellow vein virus DNA-beta satellite localizes sequences involved in replication.
(12/38)
Effect of Lonicerae Flos extracts on reflux esophagitis with antioxidant activity.
(15/38)
AIM: To observe the effects of traditional antiinflammatory medicine Lonicerae Flos (LF) on rat reflux esophagitis (RE) induced by pylorus and forestomach ligation compared with the well-known proton antioxidant, alpha-tocopherol. METHODS: Rats were pretreated with three different dosages of LF (500, 250 and 125 mg/kg) orally, once a day for 14 d before pylorus and forestomach ligation. Nine hours after pylorus and forestomach ligation, changes to the stomach and esophagus lesion areas, gastric volumes, acid and pepsin outputs, antioxidant effects, esophageal lipid peroxidation, superoxide dismutase (SOD), catalase (CAT), malondialdehyde (MDA), myeloperoxidase and glutathione (GSH) levels, and collagen contents (marker of flexibility) were observed on the esophageal and fundic histopathology. The results were compared with an alpha-tocopherol (once orally, 1 h before operation, 30 mg/kg) treated group in which the effects on RE were already confirmed. RESULTS: Pylorus and forestomach ligations caused marked increases of gross esophageal and gastric mucosa lesion areas, which corresponded with histopathological changes. In addition, increases of esophageal lipid peroxidation, decreases of SOD, CAT, and GSH-free radical scavengers, increases of collagen were observed. However, these pylorus and forestomach ligation induced RE were dose-dependently inhibited by treatment of 500, 250 and 125 mg/kg of LF extract, mediated by antioxidant effects. RE at 250 mg/kg showed similar effects alpha-tocopherol. CONCLUSION: The results suggest that antioxidant effects of LF could attenuate the severity of RE and prevent the esophageal mucosal damage, and validate its therapeutic use in esophageal reflux disease. (+info)
Luteolin isolated from the flowers of Lonicera japonica suppresses inflammatory mediator release by blocking NF-kappaB and MAPKs activation pathways in HMC-1 cells.
(16/38)